Fig. 1: Consort diagram.
From: Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial
Study procedures: patient enrollment and randomization. PET, positron emission tomography.
Fig. 1: Consort diagram. | Nature Medicine
From: Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial
Study procedures: patient enrollment and randomization. PET, positron emission tomography.
